Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

NeoGenomics Introduces Comprehensive Lung Solution & Feature Hematopathology Services At ASCO

NeoGenomics, Inc. (NASDAQ:NEO), a leading oncology testing services company, will showcase its versatile lung solution and its COMPASS® Hematopathology Services portfolio at the American Society of Clinical Oncology
byBenzinga Newsdesk
May 28, 2024
1 minute read
Total
0
Shares
0
0
0
0
0
0

NeoGenomics, Inc. (NASDAQ:NEO), a leading oncology testing services company, will showcase its versatile lung solution and its COMPASS® Hematopathology Services portfolio at the American Society of Clinical Oncology (ASCO) conference in Chicago, May 31–June 4 (booth #31093).

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Royal Gold Sold ~49,900 Gold Equivalent Ounces (GEOs) Comprised Of ~39,100 Ounces Of Gold, 556,300 Ounces Of Silver And 1,100 Tonnes Of Copper; Realized Gold, Silver And Copper Prices For Q4 Were $1,955 Per Ounce, $23.18 Per Ounce And $8,136 Per Tonne

By Benzinga Newsdesk
January 9, 10:06 AM
Royal Gold, Inc. (NASDAQ:RGLD) (together with its subsidiaries, "Royal Gold" or the "Company," "we" or "our") announced today that its wholly owned subsidiary, RGLD Gold AG, sold approximately 49,900 gold equivalent

RGLD